Skip to main content
Article
The SRD5A2 V89L polymorphism is associated with severity of disease in men with early onset prostate cancer.
The Prostate (2008)
  • John K. Scariano, University of New Mexico
  • Eric Treat, University of New Mexico
  • Frances Alba, University of New Mexico
  • Harold Nelson, University of New Mexico
  • Scott A. Ness, University of New Mexico
  • Anthony Y. Smith, University of New Mexico
Publication Date
December 1, 2008
DOI
10.1002/PROS.20842
Citation Information
John K. Scariano, Eric Treat, Frances Alba, Harold Nelson, et al.. "The SRD5A2 V89L polymorphism is associated with severity of disease in men with early onset prostate cancer." The Prostate Vol. 68 Iss. 16 (2008) p. 1798 - 1805
Available at: http://works.bepress.com/eric-treat/17/